Dissipation of potassium and proton gradients inhibits mitochondrial hyperpolarization and cytochrome c release during neural apoptosis

被引:92
作者
Poppe, M
Reimertz, C
Düssmann, H
Krohn, AJ
Luetjens, CM
Böckelmann, D
Nieminen, AL
Kögel, D
Prehn, JHM
机构
[1] Univ Munster, Fac Med, Interdisciplinary Ctr Clin Res, Res Grp Apoptosis & Cell Death, D-48149 Munster, Germany
[2] Univ Munster, Dept Pharmacol & Toxicol, D-48149 Munster, Germany
[3] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA
关键词
mitochondrial membrane potential; staurosporine; valinomycin; potassium ionophore; proton ionophore; Bcl-2; necrosis; hippocampal neurons; medulloblastoma cells;
D O I
10.1523/JNEUROSCI.21-13-04551.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Exposure of rat hippocampal neurons or human D283 medulloblastoma cells to the apoptosis-inducing kinase inhibitor staurosporine induced rapid cytochrome c release from mitochondria and activation of the executioner caspase-3. Measurements of cellular tetramethylrhodamine ethyl ester fluorescence and subsequent simulation of fluorescence changes based on Nernst calculations of fluorescence in the extracellular, cytoplasmic, and mitochondrial compartments revealed that the release of cytochrome c was preceded by mitochondrial hyperpolarization. Overexpression of the anti-apoptotic protein Bcl-xL, but not pharmacological blockade of outward potassium currents, inhibited staurosporine-induced hyperpolarization and apoptosis. Dissipation of mitochondrial potassium and proton gradients by valinomycin or carbonyl cyanide p-trifluoromethoxy-phenylhydrazone also potently inhibited staurosporine-induced hyperpolarization, cytochrome c release, and caspase activation. This effect was not attributable to changes in cellular ATP levels. Prolonged exposure to valinomycin induced significant matrix swelling, and per se also caused release of cytochrome c from mitochondria. In contrast to staurosporine, however, valinomycin-induced cytochrome c release and cell death were not associated with caspase-3 activation and insensitive to Bcl-xL overexpression. Our data suggest two distinct mechanisms for mitochondrial cytochrome c release: (1) active cytochrome c release associated with early mitochondrial hyperpolarization, leading to neuronal apoptosis, and (2) passive cytochrome c release secondary to mitochondrial depolarization and matrix swelling.
引用
收藏
页码:4551 / 4563
页数:13
相关论文
共 70 条
[1]  
Andrews FM, 1998, COMP CONT EDUC PRACT, V20, P376
[2]   Energetics in the pathogenesis of neurodegenerative diseases [J].
Beal, MF .
TRENDS IN NEUROSCIENCES, 2000, 23 (07) :298-304
[3]   The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal [J].
Bernardi, P ;
Petronilli, V .
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1996, 28 (02) :131-138
[4]   Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore [J].
Beutner, G ;
Ruck, A ;
Riede, B ;
Welte, W ;
Brdiczka, D .
FEBS LETTERS, 1996, 396 (2-3) :189-195
[5]   Early release and subsequent caspase-mediated degradation of cytochrome c in apoptotic cerebellar granule cells [J].
Bobba, A ;
Atlante, A ;
Giannattasio, S ;
Sgaramella, G ;
Calissano, P ;
Marra, E .
FEBS LETTERS, 1999, 457 (01) :126-130
[6]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[7]   Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization [J].
Bossy-Wetzel, E ;
Newmeyer, DD ;
Green, DR .
EMBO JOURNAL, 1998, 17 (01) :37-49
[8]   MitoTracker labeling in primary neuronal and astrocytic cultures:: influence of mitochondrial membrane potential and oxidants [J].
Buckman, JF ;
Hernández, H ;
Kress, GJ ;
Votyakova, TV ;
Pal, S ;
Reynolds, IJ .
JOURNAL OF NEUROSCIENCE METHODS, 2001, 104 (02) :165-176
[9]  
Castilho RF, 1998, J NEUROSCI, V18, P10277
[10]  
Dallaporta B, 1999, J IMMUNOL, V162, P6534